Flexible, Patient Capital

K2HV looks to partner with and provide capital to innovative life sciences and healthcare companies that intend to pursue aggressive development or growth plans, but also want to minimize equity dilution as they build enterprise value over the long-term. We invest in both private and public companies.

HEALTHCARE SPECIALISTS

• Experience to understand the unique needs of venture and growth stage healthcare and life sciences companies

• Deep domain knowledge to understand your products, your business and value proposition, as well as your challenges

UNIQUE SCALE AND FLEXIBILITY

• Substantial capital resources and strong financial backing; initial capital commitment of $400 million creates capacity for immediate, impactful investments

• Target investments of between $10 million and $50 million per company

• Flexible capital structure enables creative, adaptive financing solutions tailored to company needs

• Primary focus on customized debt financings, but with ability to invest in equity as well

PERMANENT FUND STRUCTURE

• Permanent capital supports a patient, long-term investment view – not tied to fixed investment time horizons or fund cycles

• Fund structure enables us to meet the increasing and evolving capital needs of our portfolio companies as they grow

• Asset base expected to grow substantially beyond the initial capital commitment over time

WHAT DRIVES US: PROFIT WITH PURPOSE

At K2HV we are driven by dual goals of Profit and Purpose, and by our fundamental desire and passion to improve outcomes for patients. We aim to enable the next generation of innovations by life sciences and healthcare companies whose success will help to further that objective.

In keeping with this mission, we have also committed to giving a percentage of our own profits back to underserved areas in healthcare.